Lexeo Therapeutics, Inc. Common Stock (LXEO) — Long-term Investment Intensity
Lexeo Therapeutics, Inc. Common Stock (LXEO) has a Long-term Investment Intensity of 25.4% as of December 2025. Long-term investments of $68.19 Million represent 25.4% of total assets of $268.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Lexeo Therapeutics, Inc. Common Stock for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lexeo Therapeutics, Inc. Common Stock Long-term Investment Intensity (2024–2025)
This chart shows how Lexeo Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the intensity stands at 25.4%, reflecting long-term investments of $68.19 Million against total assets of $268.69 Million USD. Also explore Lexeo Therapeutics, Inc. Common Stock (LXEO) total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Lexeo Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Lexeo Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Lexeo Therapeutics, Inc. Common Stock.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 25.4% | $68.19 Million | $268.69 Million | ▲ +20.6 pp |
| 2024 | 4.8% | $7.01 Million | $146.94 Million | — |